Arsenal Capital Partners

Arsenal is excited to attend the Bio-IT World Conference & Expo in Boston this April! Jeremy Goldberg, Operating Partner on the Healthcare team, will be moderating a compelling panel discussion titled “The Power Trio: How Big Tech, Pharma, and Finance are Shaping the Future of Life Sciences” as part of the Venture, Innovation & Partnering track. Panel participants include leaders from Nvidia, Google, and BMS. In addition, Dimitris K. Agrafiotis, Director of Digital, Analytics, and AI, will be sharing insights on best practices during the “Unlocking AI Potential: Best Practices for Implementation and Management” panel, part of the AI for Drug Discovery and Development track. Other members of the Arsenal team will also be in attendance, along with management team members from some of our portfolio companies — Rancho BioSciences, Endpoint Clinical, and Certara. We look forward to connecting with innovators and thought leaders who are driving the convergence of technology, science, and investment in life sciences. See you in Boston! #BioITWorld #LifeSciences #AI #DigitalHealth #PharmaInnovation #ArsenalCapitalPartners

We’re pleased to share that Nagaraja Srivatsan has been appointed CEO of Endpoint Clinical. After serving as an Advisor and Interim CEO, today’s announcement solidifies Sri’s leadership as he continues guiding Endpoint into its next phase of growth and innovation. Our focus remains the same—delivering cutting-edge RTSM solutions, exceptional service, and unwavering support for our partners. ?? Read the full release here: https://lnkd.in/efRYNDBh #Leadership #ClinicalTrials #EndpointClinical #ArsenalCapitalPartners

Earlier this week, we had the privilege of hosting our fourth annual International Women’s Day dinner, bringing together the incredible women of Arsenal—including our professionals, Senior Advisors, Management Team Members, and Board Members—to celebrate their achievements and careers. It was an energizing evening filled with meaningful conversations, networking, and professional development. A heartfelt thank you to everyone who joined us and, most importantly, to the women of Arsenal for your invaluable contributions and leadership! #InternationalWomensDay #WomenInLeadership #ArsenalCapitalPartners PC: Paolo Verzani

This past Friday, I had the honor and privilege of joining a phenomenal group of women at @Nasdaq for the International Women’s Day opening bell. This group of "risk takers and rule breakers" included women founders, executives, investors, philanthropists, and a group that is near and dear to my heart: SWIPE (Senior Women in Private Equity) Network Back in 2014 when SWIPE was first founded, it was just six women meeting up over drinks. Fast forward eleven years, there are now over 3800 members globally who are inspiring the next generation of women leaders. That is what I love most about International Women’s Day; it serves as a looking glass through which the younger generation can see that they are able to achieve anything they set their minds to. I experienced this firsthand as a family friend streamed the event for her second-grade class. It was a profound reminder of the importance of setting an example for future leaders—a responsibility I’m honored to embrace. On a personal note, my daughter took the initiative to organize a Zoom watch party for our family and friends. Moments like these remind me how fortunate I am to be surrounded by such an incredible support system.

Last week, we hosted our annual New Joiner Event, bringing together the exceptional talent that joined Arsenal over the past year. These new team members are key hires whose unique expertise and differentiated capabilities will play a critical role in advancing our strategic goals. The event featured an engaging panel with our firm’s leaders, offering insights into Arsenal’s history, culture, and track record of value creation. It was an inspiring opportunity to connect, learn, and reflect on the strength of our team. We’re excited to see how our new joiners will amplify our impact and contribute to our continued success!

We’re thrilled to be sponsoring the 2025 Women’s Private Equity Summit in Phoenix, Arizona. Our very own Lauren Gambardella, Director of Talent and Development Strategy, will be sharing her insights on the panel: “Beyond the 100-Day Plan: What’s Needed to Ensure Portfolio Companies Have the Right Team and the Right Culture?” If you’re attending, we’d love to connect. Stop by our exhibit table or reach out—we’re excited to engage with the incredible women driving the future of private equity. See you next week! Patricia Grad Elisabetta Zhang Connie Heil Alison Connor Ellen Pavlovsky (Lou) #wpes2025 #withintelligence #privateequity

We are thrilled to announce that Jon Williams, CEO of Lumanity, has been named a 2025 MM+M Pinnacle Award honoree. This esteemed recognition honors the many achievements and contributions of individuals who are redefining our industry, and we are so proud and excited to see Jon celebrated for his visionary leadership and dedication to pushing boundaries and solving our client’s toughest challenges. Please join us in congratulating Jon on this well-deserved honor. Thank you for being part of our collective Lumanity journey and congratulations to the entire class of 2025! For more information on the honorees, visit https://buff.ly/4hZ5nLu #MMMPinnacleAwards #MMM #MMMAwards #Leadership #PinnacleAward

Next week marks the start of the SCOPE Summit's 3rd Annual Clinical Trial Venture, Innovation & Partnering Conference. Jeremy Goldberg, Operating Partner on the Healthcare team, will be moderating a panel with esteemed industry leaders titled “Fueling Innovation: How Pharma Venture Arms are Transforming Clinical Trials.” Members of the Arsenal team will also be in attendance, and we look forward to engaging in insightful discussions on the future of clinical trial innovation, investment trends, and collaborative opportunities shaping the industry. If you're attending, we’d love to connect—see you in Orlando!

We are proud to share that Terrence Mullen, Managing Partner of Arsenal Capital Partners and HBS '96, recently guest lectured in a Harvard Business School Short Intensive Program (“SIP”) on Private Credit. Terry, alongside Investment Partner Roy Seroussi, contributed to a compelling HBS case study, showcasing Arsenal’s strategic decision-making process in evaluating refinancing options for a portfolio company. During the session, Terry guided the class through Arsenal’s nuanced approach, highlighting the importance of balancing financial strategy, market dynamics, and long-term value creation. Thank you to Professor Victoria Ivashina, Professor David Scharfstein, and the HBS community for the opportunity to share our insights and contribute to shaping the future of strategic decision-making in business.

Please join us in welcoming Erica Tingley as our new CFO! Tingley holds more than a decade of executive leadership experience, with extensive expertise in finance, strategy, and business development across the healthcare, technology, and private equity sectors. “Erica brings an extraordinary track record in financial leadership and a passion for driving organizational growth and excellence to Knowtion Health,” said CEO @Yardley. “Her leadership will be instrumental as we continue to advance our mission and work to achieve our ambitious goals.” Read the release: https://hubs.li/Q033dtBv0 #healthcare #revenuecycle #leadership